The safety and efficacy of bosentan in pulmonary hypertension due to congenital heart disease
R.L Benza, B.K Rayburn, J.A Tallaj, B.A Foley, L.J Pinderski, K.L Thomas, R.C BourgeVolume:
22
Year:
2003
Language:
english
DOI:
10.1016/s1053-2498(02)00937-3
File:
PDF, 51 KB
english, 2003